More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$169.16B
EPS
7.87
P/E ratio
63.2
Price to sales
17.68
Dividend yield
--
Beta
1.655253
Previous close
$478.49
Today's open
$482.78
Day's range
$475.17 - $489.51
52 week range
$425 - $609.08
show more
CEO
Gary S. Guthart
Employees
15638
Headquarters
Sunnyvale, CA
Exchange
Nasdaq Global Select
Shares outstanding
355130237
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks Investment Research • 20 hours ago

Can Intuitive Surgical Sustain Robust Top-line Growth in 2026?
ISRG posts 20.5% revenue growth in 2025, driven by higher procedure volumes and da Vinci 5 adoption, and guides for 13-15% procedure growth in 2026.
Zacks Investment Research • Feb 5, 2026

Intuitive Surgical: Buy The January Selloff
Intuitive Surgical remains a compelling long-term buy despite recent share price weakness and mixed Q4 results. Da Vinci 5 adoption is robust, with 74% YoY system placement growth and expanding FDA-approved use cases. 2026 guidance is soft, with procedure growth expected to slow to 13–15%, but headwinds are seen as temporary.
Seeking Alpha • Feb 4, 2026

Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Zacks Investment Research • Feb 3, 2026

1 No-Brainer Stock to Buy on the Dip
Intuitive Surgical's quarterly update was strong, except for its weak guidance. Still, long-term prospects for this specialist in robotic surgery remain intact.
The Motley Fool • Jan 31, 2026

Should You Buy Shares of Intuitive Surgical In February?
Intuitive Surgical is an industry leader in surgical robotics. The company continues to sell many da Vinci systems, which power its parts and services revenue.
The Motley Fool • Jan 31, 2026

Bull of the Day: Intuitive Surgical (ISRG)
Never bet against the da Vinci surgical system.
Zacks Investment Research • Jan 30, 2026

2 AI Surgery Stocks to Buy Hand Over Fist in February
Computer programs are being allowed to drive cars; it seems logical that they'll be allowed to perform surgery someday, too. Intuitive Surgical is a fast-growing company that is focused entirely on surgical robotics.
The Motley Fool • Jan 30, 2026

Forget Tech Stocks: The Medical Device Maker That's Essential to AI Healthcare
Intuitive Surgical's da Vinci surgical robots are in high demand. The high-growth company has begun incorporating AI into its technology.
The Motley Fool • Jan 27, 2026

ISRG's da Vinci Gets FDA Nod for Advanced Cardiac Procedures
Intuitive Surgical wins FDA 510(k) clearance for the da Vinci 5 system in select cardiac procedures to expand minimally invasive heart surgery.
Zacks Investment Research • Jan 27, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Intuitive Surgical Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.